S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7230 −0.30%
CLOSED · 17:40 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
KL
INSIDER · RVMD · Revolution Medicines, Inc. · DIRECTOR

Kim Lorence H.

Every open-market transaction filed under this name, Aug 31 to Aug 31.

Filings
7
0 buys · 7 sells
Bought
open market, at cost
Sold
$11.4M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 31RVMDRevolution Medicines, Inc.DirectorSell625$206.15$129K
Aug 31RVMDRevolution Medicines, Inc.DirectorSell2,128$205.19$437K
Aug 31RVMDRevolution Medicines, Inc.DirectorSell7,271$204.35$1.5M
Aug 31RVMDRevolution Medicines, Inc.DirectorSell26,160$203.55$5.3M
Aug 31RVMDRevolution Medicines, Inc.DirectorSell12,919$202.48$2.6M
Aug 31RVMDRevolution Medicines, Inc.DirectorSell6,597$201.47$1.3M
Aug 31RVMDRevolution Medicines, Inc.DirectorSell300$200.56$60K

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.